This article was published in Communicable Diseases Intelligence Vol 35 Number 2, June 2011 and may be downloaded as a full version PDF file (1854 KB).
1. National Health Security Act, No 174. 2007. Accessed on November 2009. Available from: http://www.legislation.gov.au/ComLaw/Legislation/Act1.nsf/0/A005BA0145A00248CA25736A00126AA5?OpenDocument
2. National Notifiable Diseases List. 2008. Accessed on November 2009. Available from: http://www.legislation.gov.au/ComLaw/legislation/LegislativeInstrument1.nsf/0/7162D634C6DD1BAACA25740B0079D6B8?OpenDocument
3. National Health Security Agreement. 2008. Accessed on November 2009. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-nhs-agreement.htm
4. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report, 2009: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney; 2009.
5. Klug GM, Boyd A, Lewis V, McGlade AR, Roberts H, Douglass SL, et al. Surveillance of Creutzfeldt-Jakob disease in Australia: 2008. Commun Dis Intell 2008;32(2):232–236.
6. Communicable Diseases Network Australia. National Notifiable Diseases Surveillance System. Available from: www.health.gov.au/nndssdata
7. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories, Estimated Resident Population By Single Year of Age, Australia. Canberra: Australian Bureau of Statistics; 2009. Report No.: 3201.0.
8. Australian Bureau of Statistics. Population by Age and Sex, Regions of Australia, 2009; 2010. Report No.: ABS Catalogue: 3235.0.
9. Australian Bureau of Statistics. Australian Standard Geographical Classification Concordance, 2009. Canberra: Australian Bureau of Statistics; 2010.
10. Australian Institute of Health and Welfare. National Health Data Dictionary 13.3; 2008.
11. Australian Government Department of Health and Ageing. National Hepatitis C Testing Policy; 2007.
12. National Health and Medical Research Council. The Australian Immunisation Handbook 9th edn. Canberra, Australia: Department of Health and Ageing; 2008.
13. Butler T, Papanastasiou C. National Prison Entrants’ Bloodborne Virus and Risk Behaviour Survey Report 2004 and 2007; 2008.
14. Medicare Australia. Australian Childhood Immunisation Register – Quarterly Coverage Report 30 June 2009. Canberra: Medicare Australia; 2009.
15. Medicare Australia. Australian Childhood Immunisation Register – Quarterly Coverage Report 30 September 2009. Canberra: Medicare Australia; 2009.
16. Medicare Australia. Australian Childhood Immunisation Register – Quarterly Coverage Report 31 December 2009. In. Canberra: Medicare Australia; 2009.
17. Medicare Australia. Australian Childhood Immunisation Register – Quarterly Coverage Report 31 March 2010. Canberra: Medicare Australia; 2010.
18. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report, 2010: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney; 2010.
19. Razali K, Thein HH, Bell J, Cooper-Stanbury M, Dolan K, Dore G, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007;91(2–3):228–235.
20. Gidding HF, Topp L, Middleton M, Robinson K, Hellard M, McCaughan G, et al. The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997–2006. J Gastroenterol Hepatol 2009;24(10):1648–1654.
21. Heymann DL. Control of Communicable Diseases Manual. 19th edn. Washington: American Public Health Association, USA; 2008.
22. OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell 2010;34(4):396–426.
23. Mead P, Griffin P. Escherichia coli O157:H7. Lancet 1998;352:1207–1212.
24. OzFoodNet Working Group. OzFoodNet quarterly report, 1 October to 31 December 2009. Commun Dis Intell 2010;34(1):59–67.
25. OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2007. Commun Dis Intell 2008;32(4):400–424.
26. Hanna J, Hills S, Humpreys J. Impact of hepatitis A vaccination on Indigenous children on notifications of hepatitis A in north Queensland. Med J Aust 2004;181(9):482–485.
27. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2008: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2010;34(3):157–224.
28. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2007: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2009;33(2):89–154.
29. Combs B, Raupach J, Kirk M. Surveillance of Shiga toxigenic Escherichia coli in Australia. Commun Dis Intell 2005;29(4):366–369.
30. Cumpston JHL. Health and disease in Australia. Canberra: Australian Government Publishing Service; 1989.
31. Grattan-Smith PJ, O’Regan WJ, Ellis PS, O’Flaherty SJ, McIntyre PB, Barnes CJ. Rabies. A second Australian case with a long incubation period. Med J Aust 1992;156(9):651–654.
32. World Health Organization. The Global Eradication of Smallpox: Final Report of the Global Commission for the Certification of Smallpox Eradications, Geneva, December 1979. Geneva; 1980.
33. Miller M, Roche P, Yohannes K, Spencer J, Bartlett M, Brotherton J, et al. Australia’s notifiable diseases status, 2003: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2005;29(1):1–61.
34. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to the World Health Organization. 2009. Accessed on 9 February 2009. Available from: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_02_05/en/index.html
35. Australian Government Department of Health and Ageing. Factsheets: Viral haemorrhagic fever. 2009.
36. Curran M, Harvey B, Crerar S. Annual report of the National Notifiable Diseases Surveillance System, 1996. Commun Dis Intell 1997;21(20):281–307.
37. Forssman B, Mannes T, Musto J, Gottlieb T, Robertson G, Natoli JD, et al. Vibrio cholerae O1 El Tor cluster in Sydney linked to imported whitebait. Med J Aust 2007;187(6):345–347.
38. Chen M, Fairley C, Donovan B. Nowhere near the point of diminishing returns: correlations between chlamydia testing and notification rates in New South Wales. Aust N Z J Public Health 2005;29(3):249–253.
39. Hocking J, Fairley C, Counahan M, Crofts N. The pattern of notification and testing for genital Chlamydia trachomatis infection in Victoria, 1998–2000: an ecological analysis. Aust N Z J Public Health 2003;27(4):405–408.
40. Australian Institute of Health and Welfare. Age-standardised rate – Identifying and definitional attributes. 2005. Accessed on 17 March 2010. Available from: http://meteor.aihw.gov.au/content/index.phtml/itemId/327276
41. Bowden F, Fairly C. Endemic STDs in Northern Territory: estimations of effective rates of partner change. In: Northern Territory RACP meeting; November 1996: Unpublished; 1996.
42. Queensland Health. Queensland HIV, Hepatitis C and Sexually Transmissible Infections Strategy: 2005–2011. Queensland Health; 2005.
43. Stephens N, O’Sullivan M, Coleman D, Shaw K. Chlamydia trachomatis in Tasmania 2001–2007: rising notification trends. Aust N Z J Public Health 2010;34(2):120–125.
44. Hammerschlag M. Sexually transmitted diseases in sexually abused children: medical and legal implications. Sex Transm Infect 1998;74(3):167–174.
45. Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance. The Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance Final Report to the Commonwealth Department of Health and Ageing May 31st 2010 (unpublished): The Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance; 2010.
46. Bowden FJ. Donovanosis in Australia: going, going. Sex Transm Infect 2005;81(5):365–366.
47. Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme, 2009. Commun Dis Intell 2009;34(2):89–95.
48. Tapsall JW, Limnios EA, Murphy D. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997–2006. J Antimicrob Chemother 2008;61(1):150–155.
49. Jin F, Prestage G, Zablotska I, Rawstorne P, Kippax S, Donovan T, et al. High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sex Transm Infect 2007;83(5):387–399.
50. Fairley C, Hocking J, Medland N. Syphilis: back on the rise, but not unstoppable. Med J Aust 2005;183(4):172–173.
51. Northern Territory Department of Health and Families. Northern Territory Sexual Health and Blood Borne Virus Unit Surveillance Update Vol. 10 No. 2. Northern Territory Department of Health and Families; 2009.
52. Department of Health Western Australia. The Epidemiology of Notifiable Sexually Transmitted Infections and Blood-Borne Viruses in Western Australia 2009. 2010.
53. Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine Preventable Diseases in Australia, 2005 to 2007. Commun Dis Intell 2010;34(Suppl):S1–S172.
54. Hull B, Deeks, S, Menzies, R, McIntyre, P. Immunisation coverage annual report, 2007. Commun Dis Intell 2009;33(2):170–187.
55. Lambert SB, Faux CE, Grant KA, Williams SH, Bletchly C, Catton MG, et al. Influenza surveillance in Australia: we need to do more than count. Med J Aust 2010;193(1):43–45.
56. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2010 southern hemisphere influenza season. World Health Organization; 2009.
57. Brotherton J, Wang H, Schaffer A, Quinn H, Menzies R, Hull B, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Commun Dis Intell 2007;31(Suppl):S1–S152.
58. Heywood A, Gidding H, Riddell M, McIntyre P, MacIntyre C, Kelly H. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009;87(1):64–71.
59. Aratchige P, McIntyre P, Quinn H, Gilbert G. Recent increases in mumps incidence in Australia: the ‘forgotten’ age group in 1998 Australian Measles Control Campaign. Med J Aust 2008;189(8):4.
60. Bangor-Jones R, Dowse G, Giele C, van Buynder P, Hodge M, Whitty M. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009;191(7):4.
61. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill 2009;14(50).
62. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis 2007;13(1):12–17.
63. Munoz FM. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis 2006;17(1):14–19.
64. Wendelboe AM, van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(5 Suppl):S58–S61.
65. Juretzko P, von Kries R, Hermann M, Wirsing von König CH, Weil J, Giani G. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis 2002;35(2):162–167.
66. Roberts J, Hobday L, Polychronopoulos S, Ibrahim A, Thorley B. Annual report of the Australian National Poliovirus Reference Laboratory, 2009. Commun Dis Intell 2010;34(3):277–284.
67. Australian Government Department of Health and Ageing. Communicable diseases surveillance – Highlights for 4th quarter, 2006. Commun Dis Intell 2007;31(1):135–138.
68. Fitzsimmons GJ, Wright P, Johansen CA, Whelan PI. Arboviral diseases and malaria in Australia, 2008/09: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell 2010;34(3):225–240.
69. Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect 2000;2(14):1693–1704.
70. Broom AK, Azuolas J, Hueston L, Mackenzie JS, Melville L, Smith DW, et al. Australian encephalitis: Sentinel Chicken Surveillance Programme. Commun Dis Intell 2001;25(3):157–160.
71. Western Australia Department of Health. Review of notifiable diseases 2009. Disease WAtch 2010;14(2):2–8.
72. McBride WJH. Deaths associated with dengue haemorrhagic fever: the first in Australia in over a century. Med J Aust 2005;183(1):35–37.
73. Figtree M, Lee R, Bain L, Kennedy T, Mackertich S, Urban M, et al. Plasmodium knowlesi in Human, Indonesian Borneo. Emerg Infect Dis 2010;16(4):672–674.
74. World Health Organization. Zoonoses. Technical report series no. 169. Geneva; 1959.
75. Jones KE, Patel NG, Levy MA. Global trends in emerging infectious diseases. Nature 2008(451):990–994.
76. Woolhouse MEJ, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis 2005;11(12):1842–1847.
77. World Health Organization. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases. Geneva; 2004.
78. Animal Health Australia. Animal Health in Australia 2009. Canberra; 2010.
79. Kolbe A, Yuen M, Doyle B. A case of human cutaneous anthrax. Med J Aust 2006;185(5):281–282.
80. Fielding J. Zoonoses: Anthrax. Vic Infect Dis Bull 2007(10):47.
81. Mackenzie JS. Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania. J Neurovirol 2005;11(5):434–440.
82. Allworth A, Murray K, Morgan J. A human case of encephalitis due to a Lyssavirus recently identified in fruit bats. Commun Dis Intell 1996;20(24):504.
83. Hanna JN, Carney IK, Smith GA, Tannenberg AEG, Deverill JE, Botha JA, et al. Australian bat lyssavirus infection: a second human case, with long incubation period. Med J Aust 2000;172(12):597–599.
84. Field H. The ecology of Hendra virus and Australian bat lyssavirus. 2004. Accessed on 1 August 2009. Available from: http://espace.library.uq.edu.au/eserv.php?pid=UQ:13859&dsID=field_thesis_05.pdf
85. Australian Bat Lyssavirus Focus Group. Australian Bat Lyssavirus Report, December 2008: Australian Wildlife Health Network; 2008.
86. Sweeny A, Beard F. Queensland Health Notifiable Diseases Report 2002–2006. Brisbane: Communicable Diseases Branch, Brisbane: Queensland Health; 2009
87. World Health Organization/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis. National leptospirosis surveillance report number 18, January–December 2009. Geneva: World Health Organization; 2010. Accessed on 12 September 2010. Available from: http://www.health.qld.gov.au/qhcss/qhss/lepto/documents/09_annual.pdf
88. O’Leary FM, Hunjan JS, Bradbury R, Thanakrishnan G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004;180(1):29–31.
89. Victorian Department of Human Services. Blue Book. Revised Edition 2005. Accessed on 15 August 2009. Available from: http://www.health.vic.gov.au/ideas/bluebook
90. Communicable Diseases Network Australia. Australian national notifiable diseases case definitions. 2004. Accessed on 15 July 2004. Available from: http://www.cda.gov.au/surveil/nndss/casedefs/cd_gono.htm
This issue - Vol 35 No 2, June 2011
NNDSS Annual report 2009